SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-055333
Filing Date
2006-03-16
Accepted
2006-03-15 19:49:22
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1277673
2 REFERRAL TESTING AGREEMENT dex1036.htm EX-10.36 125656
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 2365
4 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 2527
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9781
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9799
7 CERTIFICATION OF CEO & CFO PURSUANT TO RULE 13A-14(B) dex321.htm EX-32.1 5096
  Complete submission text file 0001193125-06-055333.txt   1434415
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30369 | Film No.: 06689726
SIC: 2835 In Vitro & In Vivo Diagnostic Substances